NewsBenzingaWynnefield Capital Discloses About 14.3% Stake In Lifecore Biomedical, Agrees To Vote In Favor Of Its Pending Merger, Per 13D Filing Wynnefield Capital Discloses About 14.3% Stake In Lifecore Biomedical, Agrees To Vote In Favor Of Its Pending Merger, Per 13D Filing Benzinga 2026.09.29 20:18 (GMT+0) Open on Benzinga Other news Rocket Lab Steps In Where SpaceX Just Walked Away This Analyst Says It's Time to Buy Royal Caribbean Stock. Here's Why. Stocks Settle Mixed as Bond Yields Rise Bloom Energy Is Up More Than 200% So Far This Year. What Comes Next for BE Stock. 'DEA Judge Pauses Marijuana Rescheduling Hearing As Opponents Highlight Government Report Detailing ‘Gaps’ In Federal Processes'- Marijuana Moment Carnival Files Prospectus For Offering Mixed Shelf; Terms Undisclosed
'DEA Judge Pauses Marijuana Rescheduling Hearing As Opponents Highlight Government Report Detailing ‘Gaps’ In Federal Processes'- Marijuana Moment
